Article Text
PostScript
Correspondence
Dabigatran in the setting of catheter ablation of atrial fibrillation: the road ahead
Statistics from Altmetric.com
Footnotes
-
Contributors RP has prepared the response to the letter which was revised and completed with suggestions of the three remaining authors. All authors approved the final version.
-
Competing interests RP has received honoraria for serving as a speaker and consultant for Boheringher-Ingelheim and as a co-investigator in the ENGAGE-AF TIMI 48 trial. There are no conflicts of interest by other coauthors.
-
Provenance and peer review Not commissioned; internally peer reviewed.